Estropipate combined with Ogen

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 1/1/1998 Female 1/26/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1998 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/3/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/11/2003 58 Female 12/23/2005 United States
Primary
Secondary
Metastasis Other Serious Female 2/21/2006 Lawyer United States
Primary
Secondary
Metastases To Peripheral Vascular System Other Serious Female 2/28/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 9/24/2002 Female 3/8/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/17/2000 57 Female 3/23/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2001 Female 4/10/2006 Lawyer United States
Primary
Secondary
Oedema Peripheral Other Serious 12/1/2005 82 Female 3/15/2006 United States
Primary
Concomitant
Breast Cancer Female Other Serious 3/1/2004 66 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 6/13/2000 Female 6/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/13/2000 Female 6/21/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2000 Female 7/5/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 7/12/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2001 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 7/28/2006 United States
Primary
Secondary
Ovarian Cancer Other Serious 9/24/2002 Female 6/16/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2003 53 Female 6/16/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/30/2002 Female 10/17/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 9/30/2002 Female 10/17/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 4/17/2000 63 Female 10/10/2006 United States
Primary
Secondary
White Blood Cell Count Increased Other Serious 12/23/1992 63 Female 124 lb 3/28/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2004 64 Female 12/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/13/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/1/2004 65 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Required Intervention Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2002 Female 6/22/2007 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 9/24/2002 Female 6/22/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2002 Female 9/25/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/7/2003 Female 10/16/2007 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 9/24/2002 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2002 Female 10/12/2007 United States
Primary
Secondary
Breast Cancer Other Serious 8/15/2000 65 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 5/30/2001 61 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2002 Female 2/27/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/6/2003 Female 3/31/2008 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/13/1998 Female 3/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/10/2004 Female 198 lb 5/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death 1/1/1997 Female 7/24/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1998 60 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/25/2003 68 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 4/17/2000 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2000 67 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Death Female 12/17/2008 Consumer United States
Primary
Secondary
Breast Cancer Death 11/7/2000 Female 1/20/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/18/2001 62 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/5/1999 57 Female 12/19/2008 United States
Primary
Secondary
Ovarian Cancer Other Serious 6/4/2000 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 6/13/2000 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 8/30/2002 53 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 5/9/2003 56 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 7/17/2000 66 Female 12/19/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2004 64 Female 12/19/2008 United States
Primary
Secondary
Contralateral Breast Cancer Other Serious 7/9/2002 Female 2/12/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 61 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/10/2004 Female 198 lb 3/12/2009 Consumer United States
Primary
Secondary
Ureteric Injury Other Serious 9/24/2002 Female 134 lb 3/24/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2000 Female 130 lb 3/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/17/2000 Female 4/3/2009 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 2/10/2004 Female 198 lb 4/3/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/20/2001 Female 126 lb 4/9/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 201 lb 4/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/24/2003 Female 141 lb 4/21/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/20/2002 Female 137 lb 4/22/2009 Lawyer United States
Primary
Secondary
Ovarian Cancer Other Serious 1/24/1999 Female 150 lb 4/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/11/2003 Female 200 lb 5/12/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/17/2000 Female 5/12/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 5/19/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/19/1998 Female 5/22/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2001 Female 139 lb 5/25/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/19/2002 Female 128 lb 5/26/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 9/30/2002 Female 141 lb 5/28/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2003 Female 6/5/2009 Lawyer United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 2/10/2004 60 Female 198 lb 6/4/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 Female 6/15/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/20/2000 Female 6/23/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2000 Female 7/2/2009 Lawyer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2000 Female 7/6/2009 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Death 11/7/2000 Female 7/9/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/1998 Female 154 lb 7/13/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/30/2002 Female 104 lb 7/30/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/20/2002 Female 137 lb 8/26/2009 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2000 Female 8/27/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2002 Female 8/28/2009 Lawyer United States
Primary
Secondary
Concomitant
Ovarian Cancer Other Serious 8/14/2003 Female 8/28/2009 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/2000 Female 145 lb 11/30/2009 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/19/2000 Female 145 lb 1/28/2010 United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 3/1/2010 81 Female 115 lb 5/7/2010 Consumer United States
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/19/2000 54 Female 145 lb 5/20/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 5/21/2010 Consumer United States
Primary
Secondary
Muscle Spasms Other Serious 1/1/2010 74 Female 127 lb 5/25/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/1/1998 47 Female 289 lb 4/5/2010 United States
Primary
Secondary
Oedema Peripheral Other Serious Female 6/4/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 6/4/2010 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/14/2004 65 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/14/2001 62 Female 179 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2001 50 Female 128 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/17/2002 62 Female 150 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Muscle Spasms Other Serious 1/1/2010 74 Female 127 lb 6/23/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2001 50 Female 128 lb 6/23/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/14/2001 62 Female 179 lb 6/23/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 10/14/2003 62 Female 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/10/2000 48 Female 119 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/10/2000 48 Female 119 lb 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/14/2004 65 Female 6/24/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/11/2002 59 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/5/1999 57 Female 190 lb 4/5/2010 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 6/25/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/30/2002 53 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 6/1/2003 56 Female 119 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 10/9/2000 59 Female 7/16/2010 Consumer United States
Primary
Secondary
Tympanic Membrane Perforation Other Serious Female 7/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/14/2008 64 Female 5/19/2010 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1998 Female 7/26/2010 Lawyer United States
Primary
Secondary
Peripheral Coldness Other Serious Female 110 lb 8/17/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2000 51 Female 160 lb 8/26/2010 Lawyer United States
Primary
Secondary
Peripheral Coldness Other Serious Female 110 lb 8/30/2010 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/14/2008 64 Female 9/15/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/10/2000 48 Female 9/16/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 61 Female 9/17/2010 Consumer United States
Primary
Secondary
Ovarian Cancer Other Serious 6/4/2000 54 Female 9/17/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/14/2003 62 Female 9/23/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/1998 47 Female 9/23/2010 Lawyer United States
Primary
Secondary
Nausea Female 9/24/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 7/20/2000 65 Female 10/27/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/5/1999 57 Female 10/27/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 51 Female 11/6/2010 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/14/2008 64 Female 10/12/2010 United States
Primary
Secondary
Fatigue Other Serious 1/1/2002 72 Female 10/12/2010 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 44 Female 12/2/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/5/2001 58 Female 126 lb 1/10/2011 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 11/5/2001 58 Female 126 lb 1/10/2011 Lawyer United States
Primary
Secondary
Drug Hypersensitivity 1/1/2010 74 Female 127 lb 1/19/2011 Consumer United States
Primary
Secondary
Concomitant
Blood Cholesterol Increased 1/1/1995 51 Female 110 lb 1/19/2011 Consumer United States
Primary
Secondary
Concomitant
Abdominal Pain Other Serious 1/1/2010 74 Female 127 lb 1/20/2011 Physician United States
Primary
Secondary
Concomitant
Drug Ineffective Other Serious 1/1/1995 51 Female 110 lb 1/20/2011 Consumer United States
Primary
Secondary
Concomitant
Oedema Peripheral Other Serious 1/1/1991 42 Female 235 lb 1/20/2011 Consumer United States
Primary
Secondary
Concomitant
Hypertension 1/1/1995 51 Female 110 lb 1/21/2011 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 11/5/2001 58 Female 126 lb 1/24/2011 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/14/2008 64 Female 11/7/2010 Consumer United States
Primary
Secondary

Drug Data